Highlighted Text:
Show |
Hide
Full text loading...
Chapter 1 : Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia
Author:
Dominic E. Dwyer1
VIEW AFFILIATIONS
HIDE AFFILIATIONS
Affiliations:
1: CIDM Laboratory Services, Level 3, ICPMR Building, Westmead Hospital, Westmead, NSW 2145, and Sydney Institute for Emerging Infectious Diseases and Biosecurity, University of Sydney, New South Wales, Australia
Content Type: Monograph
Publication Year:
2010
Category: Clinical Microbiology; Bacterial Pathogenesis
Book DOI:
10.1128/9781555816803
Chapter DOI:
10.1128/9781555816803.ch1
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Preview this chapter:
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555816803/9781555815257_Chap01-1.gif /docserver/preview/fulltext/10.1128/9781555816803/9781555815257_Chap01-2.gif
Abstract:
Like most countries, Australia developed plans to manage a possible influenza pandemic, stimulated by the emergence in Asia of severe acute respiratory syndrome in 2003 and zoonotic human infections with influenza A H5N1 (avian influenza). During the first wave of the 2009 pandemic, it was quickly realized that the disease was relatively mild in contrast to projected pandemic scenarios, so the Australian Health Management Plan for Pandemic Influenza (AHMPPI) was adjusted to include a “Protect” phase, where efforts were focused on protecting the vulnerable. A quarter of female hospitalized patients were either pregnant or in the postpartum period, highlighting the concerns about the severity of influenza in pregnancy. In contrast to the first pandemic wave in the Northern Hemisphere, other respiratory viruses were circulating during the Southern Hemisphere winter. Another feature of the pandemic in Australia that was different from initial Northern Hemisphere activity was that it occurred in the context of usual circulation of seasonal influenza and other respiratory viruses. A number of clinical trials of monovalent vaccines containing various doses of influenza A/California/2009 (H1N1) antigen in both adjuvanted and nonadjuvanted forms were performed in Australia and elsewhere, initially in healthy adults and children. In contrast to the early Northern Hemisphere activity, first wave occurred in the context of the usual circulation of seasonal influenza virus and respiratory viruses.
Citation:
Dwyer D.
2010.
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia,
p 1-16.
In
Scheld W, Grayson M, Hughes J (ed),
Emerging Infections 9.
ASM Press, Washington, DC.
doi: 10.1128/9781555816803.ch1
Key Concept Ranking
- Clinical and Public Health
- 0.50984836
- Severe Acute Respiratory Syndrome
- 0.4849323
- Acute Respiratory Distress Syndrome
- 0.47303212
- Influenza B virus
- 0.40819642
0.50984836
Figures
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816803.ch01-1,webId=/content/author/10.1128/9781555816803.ch01-1,properties={foaf_givenname=Dominic E., foaf_name=Dominic E. Dwyer, foaf_surname=Dwyer, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816803.ch01-aff1]]}]]
Citation:
Dwyer D.
2010.
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia,
p 1-16.
In
Scheld W, Grayson M, Hughes J (ed),
Emerging Infections 9.
ASM Press, Washington, DC.
doi: 10.1128/9781555816803.ch1
/content/10.1128/9781555816803.ch01.ch01fig01
Figure 1.
The week of peak activity of influenza-like illness measured in general practices in the different states of Australia. A.C.T., Australian Capital Territory.
10.1128/9781555816803/f0002-01_thmb.gif
10.1128/9781555816803/f0002-01.gif
Figure 1.
The week of peak activity of influenza-like illness measured in general practices in the different states of Australia. A.C.T., Australian Capital Territory.
Citation:
Dwyer D.
2010.
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia,
p 1-16.
In
Scheld W, Grayson M, Hughes J (ed),
Emerging Infections 9.
ASM Press, Washington, DC.
doi: 10.1128/9781555816803.ch1
References
/content/book/10.1128/9781555816803.ch01
1.
ANZIC Influenza Investigators et al. 2009. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N. Engl. J. Med. 361: 1925– 1934.
2.
Appuhamy, R. D.,, F. H. Beard,, H. N. Phung,, C. E. Selvey,, F. A. Birrell, and, T. H. Culleton. 2010. The changing phases of pandemic (H1N1) 2009 in Queensland: an overview of public health actions and epidemiology. Med. J. Aust. 192: 94– 97.
3.
Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators et al. 2009. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302: 1888– 1895.
4.
Australian Government Department of Health and Ageing. 2009. Australian influenza surveillance report no. 33: reporting period 19 December 2009–1 January 2010. Australian Government Department of Health and Ageing, Canberra, Australia. http://www.healthemergency.gov.au. Accessed 12 February 2010.
5.
Australian Government Department of Health and Ageing. 2008. Australian health management plan for pandemic influenza. Australian Government Department of Health and Ageing, Canberra, Australia. http://www.flupandemic.gov.au/internet/panflu/publishing.nsf/Content/ahmppi-1. Accessed 12 February 2010.
6.
Baker, M. G.,, N. Wilson,, Q. S. Huang,, S. Paine,, L. Lopez,, D. Bandaranayake,, M. Tobias,, K. Mason,, G. F. Mackereth,, M. Jacobs,, C. Thornley,, S. Roberts, and, C. McArthur. 2009. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill. 14( pii): 19319.
7.
Baz, M.,, Y. Abed,, J. Papenburg,, X. Bouhy,, M.-E. Hamelin, and, G. Boivin. 2009. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N. Engl. J. Med. 361: 2296– 2297.
8.
Braman, M. H.,, and M. J. Leung. 2010. Pandemic influenza testing at the coalface: time for reassessment? Med. J. Aust. 192: 102– 104.
9.
Bishop, J. F.,, M. P. Murnane, and, R. Owen. 2009. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N. Engl. J. Med. 361: 2591– 2594.
10.
Blyth, C. C.,, J. R. Iredell, and, D. E. Dwyer. 2009. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 361: 2493.
11.
Bradt, D. A.,, and J. Epstein. 2010. The rational clinician in a pandemic setting. Med. J. Aust. 192: 8789.
12.
Centers for Disease Control and Prevention. 2009. Swine influenza A (H1N1) infection in two children—southern California, March-April 2009. MMWR Morb. Mortal. Wkly. Rep. 58: 400– 402.
13.
Centers for Disease Control and Prevention. 2009. Hospitalized patients with novel influenza A (H1N1) virus infection—California, April-May 2009. MMWR Morb. Mortal. Wkly. Rep. 58: 536– 546.
14.
Centers for Disease Control and Prevention. 2009. Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives—12 states, 2009. MMWR Morb. Mortal. Wkly. Rep. 58: 1341– 1344.
15.
Chang, Y. S.,, S. J. van Hal,, P. M. Spencer,, I. B. Gosbell, and, P. W. Collett. 2010. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the “PROTECT” phase of the pandemic response. Med. J. Aust. 192: 90– 93.
16.
Cheng, A. C.,, D. E. Dwyer,, A. T. C. Kotsimbos,, M. Starr,, T. M. Korman,, J. P. Buttery,, C. R. Jenkins,, V. L. Krause, and, P. D. R. Johnson. 2009. ASID/TSANZ guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents. Med. J. Aust. 191: 142– 145.
17.
Clark, T. W.,, M. Pareek,, K. Hoschler,, H. Dillon,, K. G. Nicholson,, N. Groth, and, I. Stephenson. 2009. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361: 2424– 2435.
18.
Dalton, C. B.,, M. A. Cretikos,, D. N. Durrheim,, I. M. Seppelt,, W. Rawlinson, and, D. E. Dwyer. Comparison of adult patients hospitalized with pandemic (H1N1) 2009 influenza and seasonal influenza during the “Protect” phase of the pandemic response. Med. J. Aust. 192: 357– 358.
19.
Dawood, F. S.,, C. B. Dalton,, D. N. Durrheim, and, K. G. Hope. 2009. Rates of hospitalisation for acute respiratory illness and the emergence of pandemic (H1N1) 2009 virus in the Hunter New England Area Health Service. Med. J. Aust. 191: 573– 574.
20.
de Jong, M. D.,, T. T. Tran,, H. K. Truong,, M. H. Vo,, G. J. Smith,, V. C. Nguyen,, V. C. Bach,, T. Q. Phan,, Q. H. Do,, Y. Guan,, J. S. Peiris,, T. H. Tran, and, J. Farrar. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353: 2667– 2672.
21.
Denholm, J. T.,, C. L. Gordon,, P. D. Johnson,, S. S. Hewagama,, R. L. Stuart,, C. Aboltins,, C. Jeremiah,, J. Knox,, G. P. Lane,, A. R. Tramontana,, M. A. Slavin,, T. R. Schulz,, M. Richards,, C. J. Birch, and, A. C. Cheng. 2010. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med. J. Aust. 192: 84– 86.
22.
Dharan, N. J.,, L. V. Gubareva,, J. J. Meyer,, M. Okomo-Adhiambo,, R. C. McClinton,, S. A. Marshall,, K. St George,, S. Epperson,, L. Brammer,, A. I. Klimov,, J. S. Bresee,, A. M. Fry, and The Oseltamivir-Resistance Working Group. 2009. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301: 1034– 1041.
23.
Eastwood, E.,, D. N. Durrheim,, A. Jones, and, M. Butler. 2010. Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med. J. Aust. 192: 33– 36.
24.
Fielding, J. E.,, N. Higgins,, J. E. Gregory,, K. A. Grant,, M. G. Catton,, I. Bergeri,, R. A. Lester, and, H. A. Kelly. 2009. Pandemic H1N1 influenza surveillance in Victoria, Australia, April-September, 2009. Euro Surveill. 14( pii): 19368.
25.
Gordon, C. L.,, P. D. Johnson,, M. Permezel,, N. E. Holmes,, G. Gutteridge,, C. F. McDonald,, D. P. Eisen,, A. J. Stewardson,, J. Edington,, P. G. Charles,, N. Crinis,, M. J. Black,, J. Torresi, and, M. L. Grayson. 2010. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin. Infect. Dis. 50: 672– 678.
26.
Grayson, M. L.,, and P. D. R. Johnson. 2009. Australia’s influenza containment plan and the swine flu epidemic in Victoria. Med. J. Aust. 191: 150.
27.
Greenberg, M. E.,, M. H. Lai,, G. F. Hartel,, C. H. Wichems,, C. Gittleson,, J. Bennet,, G. Dawson,, W. Hu,, C. Leggio,, D. Washington, and, R. L. Basser. 2009. Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med. 361: 2405– 2413.
28.
Hancock, K.,, V. Veguilla,, X. Lu,, W. Zhong,, E. N. Butler,, H. Sun,, F. Liu,, L. Dong,, J. R. DeVos,, P. M. Gargiullo,, T. L. Brammer,, N. J. Cox,, T. M. Tumpey, and, J. M. Katz. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361: 1945– 1952.
29.
Hurt, A. C.,, J. Ernest,, Y. M. Deng,, P. Iannello,, T. G. Besselaar,, C. Birch,, P. Buchy,, M. Chittaganpitch,, S. C. Chiu,, D. Dwyer,, A. Guigon,, B. Harrower,, I. P. Kei,, T. Kok,, C. Lin,, K. McPhie,, A. Mohd,, R. Olveda,, T. Panayoto,, W. Rawlinson,, L. Scott,, D. Smith,, H. D’Souza,, N. Komadina,, R. Shaw,, A. Kelso, and, I. G. Barr. 2009. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antivir. Res. 83: 90– 93.
30.
Iwasenko, J. M., M. Cretikos,, D. L. Paterson,, R. Gibb,, S. A. Webb,, D. W. Smith,, C. C. Blyth,, D. E. Dwyer,, Q. Shi,, P. Robertson, and, W. D. Rawlinson. 2010 Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. Clin. Infect. Dis. 51: 70– 72.
31.
Kelly, H.,, G. N. Mercer, and, A. C. Cheng. 2009. Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Euro Surveill. 14( pii): 19441.
32.
Kelly, H. A. 2010. A pandemic response to a disease of predominantly seasonal intensity. Med. J. Aust. 192: 81– 83.
33.
Khandaker, G.,, B. Doyle,, D. E. Dwyer, and, R. Booy. 2010. Managing outbreaks of viral respiratory infection in aged care facilities—challenges and difficulties during the first pandemic wave. Med. J. Aust. 192: 722.
34.
Kok, J.,, C. C. Blyth,, H. Foo,, J. Patterson,, J. Taylor,, K. McPhie,, V. M. Ratnamohan,, J. R. Iredell, and, D. E. Dwyer. 2010. Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 09 and seasonal influenza A/H3N2. J. Clin. Microbiol. 48: 290– 291.
35.
Kumar, A.,, R. Zarychanski,, R. Pinto,, D. J. Cook,, J. Marshall,, J. Lacroix,, T. Stelfox,, S. Bagshaw,, K. Choong,, F. Lamontagne,, A. F. Turgeon,, S. Lapinsky,, S. P. Ahern,, O. Smith,, F. Siddiqui,, P. Jouvet,, K. Khwaja,, L. McIntyre,, K. Menon,, J. Hutchison,, D. Hornstein,, A. Joffe,, F. Lauzier,, J. Singh,, T. Karachi,, K. Wiebe,, K. Olafson,, C. Ramsey,, S. Sharma,, P. Dodek,, M. Meade,, R. Hall, and, R. A. Fowler for the Canadian Critical Care Trials Group H1N1 Collaborative. 2009. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302: 1872– 1879.
36.
La Ruche, G.,, A. Tarantola,, P. Barboza,, L. Vaillant,, J. Gueguen, and, M. Gastellu-Etchegorry for the Epidemic Intelligence Team at InVS. 2009. The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill. 14( pii): 19366.
37.
Lum, M. E.,, A. J. McMillan,, C. W. Brook,, R. Lester, and, L. S. Piers. 2009. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med. J. Aust. 191: 502– 506.
38.
McBryde, E. S.,, I. Bergeri,, C. van Gemert,, J. Rotty,, E. J. Headley,, K. Simpson,, R. A. Lester,, M. Hellard, and, J. E. Fielding. 2009. Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian State, 16 May-3 June 2009. Euro Surveill. 14( pii): 19363.
39.
New South Wales Public Health Network. 2009. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill. 14( pii): 19365.
40.
Nolan, T.,, J. McVernon,, M. Skeljo,, P. Richmond,, U. Wadia,, S. Lambert,, M. Nissen,, H. Marshall,, R. Booy,, L. Heron,, G. Hartel,, M. Lai,, R. Basser,, C. Gittleson, and, M. Greenberg. 2010. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children. A randomized trial. JAMA 303: 37– 46.
41.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360: 2605– 2615.
42.
Population Health, New South Wales Department of Health. 2010. Influenza monthly epidemiology report, NSW, January 2010. Population Health, New South Wales Department of Health, Sydney, Australia. www.health.nsw.gov.au/publichealth/Infectious/reports/influenza_05022010.asp. Accessed 20 February 2010.
43.
Speers, D. J.,, S. H. Williams,, M. Pinder,, H. R. Moody,, A. C. Hurt, and, D. W. Smith. 2010. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. Med. J. Aust. 192: 166– 168.
44.
Stuart, R. L.,, A. C. Cheng,, C. L. Marshall, and, J. K. Ferguson. 2009. ASID (HICSIG) position statement: infection control guidelines for patients with influenza-like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities. Med. J. Aust. 191: 454– 458.
45.
Taylor, J.,, K. McPhie,, J. Druce,, C. Birch, and, D. E. Dwyer. 2009. Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1 and B viruses. J. Med. Virol. 81: 1918– 1922.
46.
Tramontana, A. R.,, B. George,, A. C. Hurt,, J. S. Doyle,, K. Langan,, A. B. Reid,, J. M. Harper,, K. Thursky,, L. J. Worth,, D. E. Dwyer,, C. O. Morissey,, P. D. R. Johnson,, K. L. Buising,, S. J. Harrison,, J. F. Seymour,, P. E. Ferguson,, B. Wang,, J. T. Denholm,, A. C. Cheng, and, M. Slavin. 2010. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg. Infect. Dis. 16: 1068– 1075.
47.
Wang, B.,, D. E. Dwyer,, C. C. Blyth,, M. Soedjono,, H. Shi,, A. Kesson,, M. Ratnamohan,, K. McPhie,, A. L. Cunningham, and, N. K. Saksena. 2010. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 87: 16– 21.
Tables
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816803.ch01-1,webId=/content/author/10.1128/9781555816803.ch01-1,properties={foaf_givenname=Dominic E., foaf_name=Dominic E. Dwyer, foaf_surname=Dwyer, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555816803.ch01-aff1]]}]]
Citation:
Dwyer D.
2010.
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia,
p 1-16.
In
Scheld W, Grayson M, Hughes J (ed),
Emerging Infections 9.
ASM Press, Washington, DC.
doi: 10.1128/9781555816803.ch1
/content/10.1128/9781555816803.ch01.ch01tab01
Table 1.
Notable issues during the 2009 influenza pandemic in the Australian winter
Table 1.
Notable issues during the 2009 influenza pandemic in the Australian winter
Citation:
Dwyer D.
2010.
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia,
p 1-16.
In
Scheld W, Grayson M, Hughes J (ed),
Emerging Infections 9.
ASM Press, Washington, DC.
doi: 10.1128/9781555816803.ch1
/content/10.1128/9781555816803.ch01.ch01tab02
Table 2.
Indicators of severity of pandemic (H1N1) 2009 infection (to 20 November 2009)
Table 2.
Indicators of severity of pandemic (H1N1) 2009 infection (to 20 November 2009)
Citation:
Dwyer D.
2010.
Lessons from the Southern Hemisphere: the First Wave of the 2009 Influenza Pandemic in Australia,
p 1-16.
In
Scheld W, Grayson M, Hughes J (ed),
Emerging Infections 9.
ASM Press, Washington, DC.
doi: 10.1128/9781555816803.ch1